Experts disagree on the soundness of Connecticut and New York’s decision to continue to litigate against Purdue Pharma, as about 2,600 municipalities took an opposite approach and  settled with the drug manufacturer.

For starters, Purdue has since sought Chapter 11 bankruptcy protection, a move that could make it harder for successful litigants to collect damages. Plus, the Wall Street Journal Tuesday reported that the company has moved to shield its owners, members of the Sackler family, from lawsuits by plaintiffs who didn’t sign on to the settlement agreement.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]